Tokyo, Feb. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060666) titled 'Exploratory study of health-related functions of ONO-DA' on Feb. 13.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Self control
Primary Sponsor:
Institute - EP Mediate Co., Ltd.
Condition:
Condition - Healthy adult
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - To evaluate the health-related functions of daily intake of ONO-DA for four weeks
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Continuous intake of ONO-DA for four weeks
Eligibility:...